These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 2473564

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Changes in prostatic acid phosphatase, gamma-seminoprotein and prostate specific antigen after endocrine therapy for stage D2 prostate cancer].
    Akimoto S, Akakura K, Masai M, Isaka S, Shimazaki J.
    Hinyokika Kiyo; 1990 Jul; 36(7):783-91. PubMed ID: 1700588
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Clinical and pathological study of tumor marker in benign prostatic hypertrophy and incidental prostatic cancer].
    Sakai N, Ogawa T, Ishibashi Y, Fukuoka H, Sakanishi S.
    Hinyokika Kiyo; 1991 Jun; 37(6):589-94. PubMed ID: 1716409
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The role of prostatic specific antigen in monitoring prostatic cancer and its prognostic importance.
    Arai Y, Yoshiki T, Oishi K, Takeuchi H, Yoshida O.
    Urol Res; 1990 Jun; 18(5):331-6. PubMed ID: 1701586
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Clinical evaluation of serum gamma-seminoprotein in patients with prostatic cancer].
    Ishihara Y, Hiromoto Y, Higaki Y, Imamura K.
    Hinyokika Kiyo; 1989 Mar; 35(3):409-13. PubMed ID: 2660507
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Clinical evaluation of gamma-seminoprotein as a serum marker of prostate carcinoma].
    Sugimura Y, Sakurai M, Hioki T, Hayashi N, Yamakawa K, Tajima K, Tochigi H, Kawamura J.
    Hinyokika Kiyo; 1988 Dec; 34(12):2129-34. PubMed ID: 2467541
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Measurements of serum gamma-seminoprotein and prostate specific antigen evaluated for monitoring carcinoma of the prostate.
    Siddall JK, Shetty SD, Cooper EH.
    Clin Chem; 1986 Nov; 32(11):2040-3. PubMed ID: 2430732
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Benign prostatic hypertrophy with high levels of gamma-seminoprotein (gamma-Sm), prostate specific antigen: report of two cases].
    Asakawa M, Yasumoto R, Kamizuru M, Maekawa M.
    Hinyokika Kiyo; 1988 Dec; 34(12):2189-91. PubMed ID: 2467544
    [Abstract] [Full Text] [Related]

  • 36. Prostate-specific antigen in prostate cancer.
    Kuriyama M.
    Int J Biol Markers; 1986 Dec; 1(2):67-76. PubMed ID: 2448397
    [Abstract] [Full Text] [Related]

  • 37. Immunological comparison between prostate-specific antigen and gamma-seminoprotein.
    Deguchi T, Kuriyama M, Shinoda I, Okano M, Ban Y, Matsui H, Yamada A, Saito I, Kawada Y.
    Urol Res; 1991 Dec; 19(1):25-30. PubMed ID: 1709312
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Usefulness of prostate specific antigen/gamma-seminoprotein ratio for diagnosis of prostate cancer].
    Demura T, Watarai Y, Togashi M, Oohashi N, Chikaraishi T, Hirano T.
    Nihon Hinyokika Gakkai Zasshi; 1993 Jun; 84(6):1046-53. PubMed ID: 7688442
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.